KFF graphic featuring a quote from Juliette Cubanski, KFF Deputy Director of the Program on Medicare Policy. It says, “CMS’s efforts to expand Medicare coverage of GLP-1s for obesity could provide substantial benefits to millions of Medicare beneficiaries, given the potential demand for these highly effective medications…There are potential drawbacks to the short-term program, however.”
⚡ KFF’s @jcubanski.bsky.social explains what Medicare’s temporary program to expand GLP-1 coverage to include obesity means for beneficiaries. #QuickTake https://on.kff.org/4bgInFZ